| Issue Type | XXXX |
|---|---|
| Country | Switzerland |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2025-07-09 |
| Par Value | 5000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 270.00 |
| Coupon | 1.05 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 270 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Ferring Holding SA corporate bond has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million CHF and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Ferring Holding SA, founded in 1950 and headquartered in Switzerland, is a global biopharmaceutical group focused on the research, development, and commercialization of innovative medicines. The company primarily specializes in reproductive health, urology, and gastroenterology, with a strong commitment to improving patient outcomes through advanced therapies.